Regulatory status record
Cough syrup rules in India (2026): prescription only, warnings for children under 4
Last checked 8 October 2026
Cough syrups are not banned in India as of 8 Oct 2026, but since 15 Jun 2026 they are no longer exempt for over-the-counter sale (G.S.R. 477(E)); chlorpheniramine with phenylephrine combinations must carry a 'not for children below four' warning (S.O. 4595(E)), and on 18 Sep 2026 the Drugs Consultative Committee recommended a red under-4 warning on every cough syrup.
- Classification
- Restricted under Section 26A, Drugs and Cosmetics Act, 1940
- Decided by
- Ministry of Health and Family Welfare; CDSCO; Drugs Consultative Committee
- Reference
- G.S.R. 477(E), 9 Jun 2026 (published 15 Jun 2026); S.O. 4595(E), 18 Aug 2026; minutes of the 70th DCC meeting, 18 Sep 2026; G.S.R. 607(E), 8 Jul 2026
- Latest action
- 18 September 2026
- Last checked
- 8 October 2026
Photo: Cocillana.JPG by unknown (CC0). All photo credits.
G.S.R. 477(E): Drugs (Fifth Amendment) Rules, 2026
Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Below: Blacklisted's explanationWe organise and explain what the document says. The document above is the authority.
Key facts
- OTC sale
- Ended. 'Syrups' removed from the Schedule K exemption by G.S.R. 477(E) (Drugs Fifth Amendment Rules, 2026), in force on publication, 15 Jun 2026
- CPM + phenylephrine
- All FDCs restricted: label, insert and promotion must say they shall not be used in children below four years (S.O. 4595(E), 18 Aug 2026)
- Red warning for all cough syrups
- Recommended by the 70th DCC on 18 Sep 2026: 'WARNING: Cough syrup shall not be used in children below 4 years of age', larger font, no images of infants, toddlers or toys. Needs a Rule 96 amendment before it is law
- High-alcohol oral liquids
- Over 12% alcohol in packs above 30 ml move to Schedule H1 (G.S.R. 607(E), 8 Jul 2026), effective six months after publication, around January 2027
- Children under 2
- DGHS advisory of 4 Oct 2025: cough and cold syrups should not be prescribed or dispensed to children under two
- Is any cough syrup banned?
- Specific combinations are, on the banned drugs list (for example several 2024 FDCs), and contaminated brands such as Coldrif were withdrawn. Cough syrups as a class are not
Three changes in 2026 have tightened how cough syrups are sold in India, without banning them. The first, and the one most people notice, is that cough syrups are no longer over-the-counter medicines. Schedule K of the Drugs Rules had let syrups be sold without a prescription; the Drugs (Fifth Amendment) Rules, 2026, notified as G.S.R. 477(E) and in force from 15 Jun 2026, removed that exemption. The draft had been published on 30 Dec 2025, after the cough syrup deaths of late 2025.
The second is about young children. Since April 2025 some drops of chlorpheniramine with phenylephrine had to say they are not for children under four; S.O. 4595(E) of 18 Aug 2026 extended that warning to every combination of the two drugs, on the label, the package insert and promotional material. On 18 Sep 2026 the Drugs Consultative Committee went further and agreed in principle that every cough syrup should carry a prominent red warning, 'Cough syrup shall not be used in children below 4 years of age', and that labels should not show infants, toddlers or toys. That needs an amendment to Rule 96 and a gazette notification before it binds anyone.
The third is G.S.R. 607(E) of 8 Jul 2026, which moves oral liquids with more than 12% alcohol in packs above 30 ml into Schedule H1, with stricter record-keeping, from about January 2027. Separately, specific combinations remain on the banned drugs list, and contaminated brands such as Coldrif, Respifresh TR and ReLife were withdrawn in 2025; those are recorded on their own pages.
What this means for you
Expect to be asked for a prescription
Since June 2026 a chemist should not sell a cough syrup without a prescription. Lozenges and other forms are covered by their own rules.
Do not give cough syrup to young children without a doctor
The advisory for under-twos and the warnings for under-fours point the same way. Most coughs in small children need fluids and rest, not syrup.
The red warning is not law yet
The committee recommended it. It becomes compulsory only after the rules are amended and notified. We will update this page when that happens.
This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.
Common questions
Are cough syrups banned in India?
No. Since 15 Jun 2026 they need a prescription, and some specific combinations are banned, but cough syrups as a class are on sale.
Can I buy cough syrup without a prescription?
Not lawfully since 15 Jun 2026, when G.S.R. 477(E) removed syrups from the Schedule K over-the-counter exemption.
Which cough syrups are banned for children?
Combinations of chlorpheniramine and phenylephrine must carry a warning not to use them below four years. A red under-4 warning for every cough syrup has been recommended but not yet notified.
Ingredient records
Every banned combination and failed batch containing each ingredient.
Official sources and primary records
- G.S.R. 477(E): Drugs (Fifth Amendment) Rules, 2026GazetteGazette of India (MoHFW) · 15 June 2026
- G.S.R. 607(E): Drugs (Tenth Amendment) Rules, 2026GazetteGazette of India (MoHFW) · 9 July 2026
- Minutes of the 70th Drugs Consultative Committee meeting, 18 Sep 2026RegulatorCDSCO · 30 September 2026
- Govt restricts use of chlorpheniramine and phenylephrine combinations for children below 4NewsAll India Radio · 22 August 2026
- CDSCO recommends ban on infant, toddler imagery and red warning on cough syrup labelsNewsThe South First · 4 October 2026